Several strategies are being explored to overcome MDR. These include the development of inhibitors that block efflux pumps, combination therapies that use multiple drugs to bypass resistance mechanisms, and the design of novel drugs that are not substrates for common resistance pathways. Additionally, nanotechnology offers promising avenues for delivering drugs directly to target cells, minimizing the impact of MDR.
